Impact of Multiple Kidney Retransplants on Post-Transplant Outcomes in the United States

被引:0
|
作者
Thongprayoon, Charat [1 ]
Valencia, Oscar A. Garcia [1 ]
Miao, Jing [1 ]
Craici, Iasmina M. [1 ]
Mao, Shennen A. [2 ]
Mao, Michael A. [3 ]
Tangpanithandee, Supawit [1 ]
Pham, Justin H. [1 ]
Leeaphorn, Napat [1 ]
Cheungpasitporn, Wisit [1 ]
机构
[1] Mayo Clin, Dept Med, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Transplant Surg, Jacksonville, FL USA
[3] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Jacksonville, FL USA
关键词
TRANSPLANTATION; SURVIVAL; 3RD; DIALYSIS; RISK;
D O I
10.1016/j.transproceed.2024.12.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Kidney retransplantation offers a valuable treatment option for patients who experience graft failure after their initial transplant. There is an increasing number of patients undergoing multiple retransplants. However, the impact of multiple kidney retransplants on post- transplant outcomes remains unclear. This study aimed to assess the association between the number of kidney retransplants and post-transplant outcomes in kidney retransplant recipients. Methods. We used the Organ Procurement and Transplantation Network and United Network for Organ Sharing (OPTN/UNOS) database to identify kidney-only retransplant recipients in United States from 2010 through 2019. We categorized kidney retransplant recipients based on their number of kidney retransplant into one and two plus kidney retransplant groups. The association of one vs two plus kidney retransplants with death-censored graft failure and patient death was assessed using Cox proportional hazard analysis, and acute rejection using logistic regression analysis. Results. Of 17,433 kidney retransplant recipients included in this study, 15,821 (91%) and 1612 (9%) had one and two plus kidney retransplants, respectively. Patients with two plus kidney retransplants were younger, predominantly White, had higher panel reactive antibody (PRA), public insurance, and education, but had less history of diabetes mellitus and total HLA mismatch compared with patients with one kidney retransplant. After adjusting for potential confounders, having two plus kidney retransplants was significantly associated with increased risk of death-censored graft failure (hazard ratio [HR] = 1.20, 95% confidence interval [CI] = 1.021.42) and allograft rejection (odds ratio [OR] = 1.30, 95% CI = 1.09-1.54), but it was not signifi- cantly associated with patient death. Conclusions. Patients undergoing multiple kidney retransplants face a higher risk of graft failure and rejection compared with those with a single retransplant. These findings underscore the need for tailored management and monitoring strategies to improve outcomes for patients receiving multiple kidney retransplants.
引用
收藏
页码:214 / 222
页数:9
相关论文
共 50 条
  • [31] Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
    Shivaswamy, Vijay
    Boerner, Brian
    Larsen, Jennifer
    ENDOCRINE REVIEWS, 2016, 37 (01) : 37 - 61
  • [32] Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis
    Okada, Yosuke
    Takenaka, Katsuto
    Murata, Makoto
    Shimazu, Yutaka
    Tachibana, Takayoshi
    Ozawa, Yukiyasu
    Uchida, Naoyuki
    Wakayama, Toshio
    Doki, Noriko
    Sugio, Yasuhiro
    Tanaka, Masatsugu
    Masuko, Masayoshi
    Kobayashi, Hikaru
    Ino, Kazuko
    Ishikawa, Jun
    Nakamae, Hirohisa
    Matsuoka, Ken-ichi
    Kanda, Yoshinobu
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Nagamura-Inoue, Tokiko
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1076 - 1085
  • [33] POST-TRANSPLANT RENAL FUNCTION: TRENDS AND IMPACT ON SURVIVAL OUTCOMES
    Chang, S. H.
    Chadban, S. J.
    McDonald, S. P.
    NEPHROLOGY, 2007, 12 : A28 - A28
  • [34] The impact of SGLT2 inhibitors on clinical outcomes in kidney transplant recipients with post-transplant diabetes mellitus.
    Ko, Myeonghyeon
    Kim, Sangwan
    Ahn, Jayeon
    Lee, Jisun
    Han, Ahram
    Ha, Jongwon
    Lee, Juhan
    Huh, Kyuha
    Min, Sangil
    TRANSPLANTATION, 2024, 108 (09) : 400 - 400
  • [35] The impact of SGLT2 inhibitors on clinical outcomes in kidney transplant recipients with post-transplant diabetes mellitus.
    Ko, Myeonghyeon
    Kim, Sangwan
    Ahn, Jayeon
    Lee, Jisun
    Han, Ahram
    Ha, Jongwon
    Lee, Juhan
    Huh, Kyuha
    Min, Sangil
    TRANSPLANTATION, 2024, 108 (9S)
  • [36] Outcomes in Kidney Transplant Recipients With Post-Transplant DSA in the Absence of Antibody Mediated Rejection
    Osadchuk, L.
    Astor, B.
    Ellis, T.
    Kaufman, D.
    Brar, J.
    Djamali, A.
    Muth, B.
    Mohamed, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 467 - 467
  • [37] Effect of pre and post-transplant body mass index on pediatric kidney transplant outcomes
    Abdelrahman, Safaa M.
    Samir, Basma
    Abd Alazem, Eman Abobakr
    Musa, Noha
    BMC PEDIATRICS, 2022, 22 (01)
  • [38] Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes
    Lentine, K.
    Lam, N.
    Segev, D.
    Axelrod, D.
    Zhang, Z.
    Xiao, H.
    Hess, G.
    Kasiske, B.
    Gadi, R.
    Devraj, R.
    Brennan, D.
    Randall, H.
    Schnitzler, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 292 - 293
  • [39] Early post-transplant leukopenia in heart transplant recipients and its impact on outcomes
    Batra, Jaya
    DeFilippis, Ersilia M.
    Golob, Stephanie
    Lumish, Heidi
    Clerkin, Kevin
    Topkara, Veli K.
    Restaino, Susan
    Lee, Sun Hi
    Latif, Farhana
    Raikhelkar, Jayant
    Fried, Justin
    Oh, Kyung Taek
    Lin, Edward
    Colombo, Paolo C.
    Yuzefpolskaya, Melana
    Sayer, Gabriel
    Uriel, Nir
    CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [40] IMPACT OF POST-TRANSPLANT BODY MASS INDEX TRAJECTORY ON LIVER TRANSPLANT OUTCOMES
    Wang, Roy
    Mahmud, Nadim
    HEPATOLOGY, 2024, 80 : S1020 - S1021